Pfizer’s subsidiary Biohaven has agreed to a settlement nearing $60 million to resolve allegations of false claims related to improper physician remuneration. This settlement marks a pivotal moment in ...
In a recent episode of Oncology Unscripted, Dr. John Marshall, a renowned oncologist from Georgetown University, delves into the complex economics of cancer care in early 2025. As the new ...